Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 9/20 | 0.33 |
| ▸ | BCHE | P06276 | 8/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL679623 | 0.76 | — | — | |
| SCHEMBL5535219 | 0.74 | — | — | |
| SCHEMBL2629342 | 0.73 | — | — | |
| SCHEMBL12255168 | 0.70 | CCNB2 (0.36) | TYRACHEAPEX1 | |
| SCHEMBL5538019 | 0.69 | TDP1 (0.35) | — | |
| SCHEMBL25626148 | 0.68 | — | — | |
| SCHEMBL5536581 | 0.68 | MAPT (0.37) | — | |
| SCHEMBL5833261 | 0.67 | — | — | |
| SCHEMBL22792609 | 0.67 | — | — | |
| SCHEMBL15229474 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841328-B2 | Selective insecticides based on anthranilic acid diamides and safeners | BAYER CROPSCIENCE AG (DE) | 2014-09-23 | — | — | US | disclosed |
| US-8841328-B2 | Selective insecticides based on anthranilic acid diamides and safeners | BAYER CROPSCIENCE AG (DE) | 2014-09-23 | — | — | US | disclosed |
| US-20140087946-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-20140087946-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-8017632-B2 | for controlling insects and/or arachnids | BAYER CROPSCIENCE AG (DE) | 2011-09-13 | — | — | US | disclosed |
| US-8017632-B2 | for controlling insects and/or arachnids | BAYER CROPSCIENCE AG (DE) | 2011-09-13 | — | — | US | disclosed |
| US-20110059991-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER CROPSCIENCE AG (DE) | 2011-03-10 | — | — | US | disclosed |
| US-20110059991-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | BAYER CROPSCIENCE AG (DE) | 2011-03-10 | — | — | US | disclosed |
| US-20080221167-A1 | for controlling insects and/or arachnids | BAYER CROPSCIENCE AG (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080221167-A1 | for controlling insects and/or arachnids | BAYER CROPSCIENCE AG (DE) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140087946-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | DDC, DDT, AADAC | TYR 1084/4885ACHE 1071/4885BCHE 3074/4885 |
| US-20110059991-A1 | Selective Insecticides Based on Anthranilic Acid Diamides and Safeners | DDC, DDT, AADAC | TYR 1084/4885ACHE 1071/4885BCHE 3074/4885 |
| US-20080221167-A1 | for controlling insects and/or arachnids | CRYAB, DDC, DDT | TYR 580/4885ACHE 387/4885BCHE 1989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.